5 Papers
34 Citations
Ron Ram is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Transplantation & Internal medicine. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia
Ron Ram,Rainer Storb,Brenda M. Sandmaier,David G. Maloney,Ann E. Woolfrey,Mary E.D. Flowers,Michael B. Maris,Gina G. Laport,Thomas R. Chauncey,Thoralf Lange,Amelia Langston,Barry E. Storer,George E. Georges +12 more
TL;DR: For patients with high-risk acute lymphoblastic leukemia in first complete remission, non-myeloablative conditioning and allogeneic hematopoietic cell transplantation, with post-grafting imatinib for Philadelphia chromosome-positive disease, can result in favorable long-term survival.
96
Association Between Calcineurin Inhibitor Blood Concentrations and Outcomes After Allogeneic Hematopoietic Cell Transplantation
Ron Ram,Barry E. Storer,Barry E. Storer,Marco Mielcarek,Marco Mielcarek,Brenda M. Sandmaier,Brenda M. Sandmaier,David G. Maloney,David G. Maloney,Paul J. Martin,Paul J. Martin,Mary E.D. Flowers,Mary E.D. Flowers,Bee K. Chua,Marcello Rotta,Rainer Storb,Rainer Storb +16 more
TL;DR: It is concluded that higher cyclosporine concentrations relatively early after nonmyeloablative HCT confer protection against aGVHD that translates into reduced risks of nonrelapse and overall mortality.
44
Histology and Time to Progression Predict Survival for Lymphoma Recurring after Reduced-Intensity Conditioning and Allogeneic Hematopoietic Cell Transplantation
Ron Ram,Ted Gooley,David G. Maloney,David G. Maloney,Oliver W. Press,Oliver W. Press,John M. Pagel,John M. Pagel,Stephen H. Petersdorf,Stephen H. Petersdorf,Andrei R. Shustov,Andrei R. Shustov,Mary E.D. Flowers,Mary E.D. Flowers,Paul O'Donnell,Paul O'Donnell,Brenda M. Sandmaier,Brenda M. Sandmaier,Rainer Storb,Rainer Storb,Ajay K. Gopal,Ajay K. Gopal +21 more
TL;DR: It is concluded that despite relapse of lymphoma after RIC HCT, some patients may experience prolonged survival, with better postrelapse outcomes occurring in patients with indolent NHL, HL, or late relapse.
32
Outcomes of Early Relapse Following Non-Myeloablative Allogeneic Transplant for Lymphoma.
Ron Ram,Ted Gooley,David G. Maloney,Oliver W. Press,John M. Pagel,Stephen H. Petersdorf,Andrei R. Shustov,Mary E.D. Flowers,Brenda M. Sandmaier,Rainer Storb,Ajay K. Gopal +10 more
TL;DR: The survival as well as factors associated with outcomes for lymphoma patients experiencing relapse within 200 days of NMAT are described and a post-transplant platform of a chemotherapy-naive graft for both myelosuppressive and immune-mediated anti-tumor therapies is provided.
2
Reduced Intensity Conditioning with Allogeneic Hematopoietic Cell Transplantation for the Treatment of High-Risk Acute Lymphoblastic Leukemia.
Ron Ram,Rainer Storb,David G. Maloney,Brenda M. Sandmaier,Michael B. Maris,Judith A. Shizuru,Thomas R. Chauncey,Amelia Langston,George E. Georges +8 more
TL;DR: The transplantation course and overall survival (OS) of 50 consecutive pts with high-risk ALL that were treated in a multi-center protocol of RIC and allogeneic HCT between February 2000 and August 2008 are described.
2